Skip to search formSkip to main contentSkip to account menu

LJP 394

Known as: LJP-394 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

ABETIMUS SODIUMabetimus

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
LJP-394 (abetimus sodium) in the treatment of systemic lupus erythematosus
Renal disease is one of the most severe aspects of systemic lupus erythematosus (SLE), potentially leading to irreversible kidney… 
Review
2002
Review
2002
How to manage patients with lupus nephritis.
  • J. Esdaile
  • Baillière's Best Practice & Research : Clinical…
  • 2002
  • Corpus ID: 28055390
The clinical and renal biopsy predictors of assistance in determining therapy are reviewed. While pulse cyclophosphamide remains… 
Review
2001
Review
2001
Novel therapies in the treatment of systemic lupus erythematosus.
This review highlights the advances made in the use of biological and immunomodulatory agents in systemic lupus erythematosus… 
2000
2000
LJP-394 reduces the incidence and time to occurrence of renal flares in patients with lupus
  • 2000
  • Corpus ID: 195149247
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)